Skip to Content

'
Prajnan Das, M.D., M.S., M.P.H.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Program Director, Residency and Fellowship, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2003 Harvard School of Public Health, Boston, MA, MPH, Clinical Effectiveness
1999 Harvard Medical School, Boston, MA, MD, cum laude, Medicine
1995 Stanford University, Stanford, CA, BS, Honors and Distinction, Biological Sciences
1995 Stanford University, Stanford, CA, MS, Biological Sciences

Postgraduate Training

7/2000-6/2004 Clinical Residency, Radiation Oncology, Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA
6/1999-6/2000 Clinical Internship, Internal Medicine, Brigham and Women's Hospital, Boston, MA

Board Certifications

2005 American Board of Radiology, Radiation Oncology

Experience/Service

Administrative Appointments/Responsibilities

Vice Chair, Institutional Review Board 1, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2010-present

Honors and Awards

2012 Multi-Year Appointment Award, The University of Texas MD Anderson Cancer Center
2008 Luis Delclos Award for Excellence in Teaching, The University of Texas M. D. Anderson Cancer Center
1999 cum laude, Harvard Medical School
1995 Honors and Distinction, Stanford University
1994 Phi Beta Kappa, Stanford University

Selected Publications

Peer-Reviewed Original Research Articles

1. Das P, Eng C, Rodriguez-Bigas M, Chang GJ, Skibber JM, You YN, Maru DM, Munsell MF, Clemons MV, Kopetz SE, Garrett CR, Shureiqi I, Delclos ME, Krishnan S, Crane CH. Preoperative Radiation Therapy with Concurrent Capecitabine, Bevacizumab and Erlotinib for Rectal Cancer: A Phase I Trial. Int J Radiat Oncol Biol Phys. In Press.
2. Das P, Johnson J, Hayden SE, Riley BA, Harrelson S, Gillin M, Ibbott G, Buchholz TA. Rate of radiation therapy events in a large academic institution. J Am Coll Radiol 10(6):452-455, 6/2013. PMID: 23735271.
3. Guadagnolo BA, Huo J, Liao KP, Buchholz TA, Das P. Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States. Cancer 119(5):1089-1097, 3/2013. e-Pub 11/2012. PMID: 23132206.
4. Kelly P, Das P, Pinnix CC, Beddar S, Briere T, Pham M, Krishnan S, Delclos ME, Crane CH. Duodenal Toxicity after Fractionated Chemoradiation for Unresectable Pancreatic Cancer. Int J Radiat Oncol Biol Phys 85(3):e143-149, 3/2013. e-Pub 11/2012. PMID: 23200173.
5. Mitchell MP, Abboud M, Eng C, Beddar AS, Krishnan S, Delclos ME, Crane CH, Das P. Intensity-Modulated Radiation Therapy with Concurrent Chemotherapy for Anal Cancer: Outcomes and Toxicity. Am J Clin Oncol. e-Pub 3/2013. PMID: 23466576.
6. Mirnezami R, Chang GJ, Das P, Chandrakumaran K, Tekkis P, Darzi A, Mirnezami AH. Intraoperative radiotherapy in colorectal cancer: systematic review and meta-analysis of techniques, long-term outcomes, and complications. Surg Oncol 22(1):22-35, 3/2013. e-Pub 12/25/2012. PMID: 23270946.
7. Albert JM, Das P. Quality Indicators in Radiation Oncology. Int J Radiat Oncol Biol Phys 85(4):904-911, 3/2013. e-Pub 10/2012. PMID: 23040217.
8. Habra MA, Ejaz S, Feng L, Das P, Deniz F, Grubbs EG, Phan A, Waguespack SG, Ayala-Ramirez M, Jimenez C, Perrier ND, Lee JE, Vassilopoulou-Sellin R. A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma. J Clin Endocrinol Metab 98(1):192-197, 2013.
9. Das P, Minsky BD. A Watch-and-Wait Approach to the Management of Rectal Cancer. Oncology (Williston park) 27:962-968, 2013.
10. Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 100(8):1109-1014, 2013.
11. Das P, Abboud MT, Haque W, Javle M, Kaseb A, Curley SA, Vauthey JN, Aloia TA, Beddar AS, Delclos ME, Krishnan S, Crane CH. Gastric Bleeding After Radiation Therapy for Intrahepatic Cholangiocarcinoma. Prac Radiat Oncol 3(4):344-348, 2013.
12. Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, Scott WJ, Strong VE, Varghese TK Jr, Warren G, Washington MK, Willett C, Wright CD, McMillian NR, Sundar H. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 11(5):531-546, 2013.
13. Eng C, Chang GJ, You YN, Das P, Xing Y, Delclos M, Wolff RA, Rodriguez-Bigas MA, Skibber J, Ohinata A, Gould S, Phillips J, Crane CH. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal. Cancer 119(21):3769-75, 2013.
14. Skinner HD, Crane CH, Garrett CR, Eng C, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Kelly P, Sandulache VC, Delclos ME, Krishnan S, Das P. Metformin use and improved response to therapy in rectal cancer. Cancer Med 2(1):99-107, 2013.
15. Agarwal A, Chang GJ, Hu CY, Taggart M, Rashid A, Park IJ, You YN, Das P, Krishnan S, Crane CH, Rodriguez-Bigas M, Skibber J, Ellis L, Eng C, Kopetz S, Maru DM. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer, 2013.
16. Briere TM, Crane CH, Beddar S, Bhosale P, Mok H, Delclos ME, Krishnan S, Das P. Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patients. Radiother Oncol 104(2):161-166, 8/2012. e-Pub 7/2012. PMID: 22841019.
17. Schoenfeld JD, Mauch PM, Das P, Silver B, Marcus KJ, Stevenson MA, Ng AK. Lung malignancies after Hodgkin lymphoma: Disease characteristics, detection methods and clinical outcome. Ann Oncol 23(7):1813-8, 7/2012. e-Pub 11/2011. PMID: 22104573.
18. Albert JM, Das P. Quality assessment in oncology. Int J Radiat Oncol Biol Phys 83(3):773-781, 7/2012. e-Pub 3/2012. PMID: 22445001.
19. Chakravarty T, Crane CH, Ajani JA, Mansfield PF, Briere TM, Beddar AS, Mok H, Reed VK, Krishnan S, Delclos ME, Das P. Intensity Modulated Radiation Therapy with Concurrent Chemotherapy as Preoperative Treatment for Localized Gastric Adenocarcinoma. Int J Radiat Oncol Biol Phys 83(2):581-586, 6/1/2012. e-Pub 12/2/2011. PMID: 22137021.
20. Park IJ, You YN, Agarwal A, Skibber JM, Rodriguez-Bigas MA, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Hu CY, Chang GJ. Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer. J Clin Oncol 30(15):1770-1776, 5/2012. e-Pub 4/2012. PMCID: PMC3383178.
21. Kelly P, Das P, Varadhachary GR, Fontanilla HP, Krishnan S, Delclos ME, Jhingran A, Eifel PJ, Crane CH. Role of Definitive Radiation Therapy in Carcinoma of Unknown Primary in the Abdomen and Pelvis. Int J Radiat Oncol Biol Phys 82(5):2012-2017, 4/2012. e-Pub 6/2011. PMID: 21640510.
22. Jones WE 3rd, Thomas CR Jr, Herman JM, Abdel-Wahab M, Azad N, Blackstock W, Das P, Goodman KA, Hong TS, Jabbour SK, Konski AA, Koong AC, Rodriguez-Bigas M, Small W Jr, Zook J, Suh WW. ACR Appropriateness Criteria  Resectable Rectal Cancer. Radiat Oncol 7:161, 2012.
23. Suzuki A, Xiao L, Taketa T, Blum MA, Matamoros A Jr, Chien PL, Mansfield PF, Fournier KF, Weston B, Lee JH, Bhutani MS, Estrella JS, Delclos ME, Krishnan S, Das P, Ajani JA. Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experience. Oncology 82(6):347-351, 2012.
24. Skinner HD, Sharp HJ, Kaseb AO, Javle MM, Vauthey JN, Abdalla EK, Delclos ME, Das P, Crane CH, Krishnan S. Radiation treatment outcomes for unresectable hepatocellular carcinoma. Acta Oncol 50(8):1191-1198, 11/2011. e-Pub 7/27/2011. PMID: 21793641.
25. Tsai CJ, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BW, Eng C, Krishnan S, Maru DM, Das P. Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer 117(16):3713-3722, 8/15/2011. e-Pub 2/15/2011. PMID: 21328329.
26. Crane CH, Varadhachary GR, Yordy JS, Staerkel GA, Javle MM, Safran H, Haque W, Hobbs BD, Krishnan S, Fleming JB, Das P, Lee JE, Abbruzzese JL, Wolff RA. Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression. J Clin Oncol 29(22):3037-3043, 8/1/2011. e-Pub 6/27/2011. PMCID: PMC3157965.
27. Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD. Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw 9(8):830-887, 8/2011. PMID: 21900218.
28. Tan CH, Bhosale PR, Das P, Crane CH, Viswanathan C, Raval B, Eng C, Iyer RB. Multidetector Computed Tomography Follow-up of Hypoattenuating Small Liver Lesions in Patients With Rectal Cancer. Am J Clin Oncol 34(4):411-416, 8/2011. PMID: 20686401.
29. Mak RH, McCarthy EP, Das P, Hong TS, Mamon HJ, Hoffman KE. Adoption of Preoperative Radiation Therapy for Rectal Cancer From 2000 to 2006: A Surveillance, Epidemiology, and End Results Patterns-of-Care Study. Int J Radiat Oncol Biol Phys 80(4):978-984, 7/2011. e-Pub 10/2010. PMID: 20961695.
30. Mok H, Briere TM, Martel MK, Beddar S, Delclos ME, Krishnan S, Crane CH, Das P. Comparative analysis of volumetric modulated arc therapy versus intensity modulated radiation therapy for radiotherapy of anal carcinoma. Prac Radiat Oncol 1(3):163-172, 7/2011.
31. Das P, Ng A, Constine LS, Advani R, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ. ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II. J Am Coll Radiol 8(5):302-308, 5/2011. PMID: 21531305.
32. Dabaja BS, Rebueno NC, Mazloom A, Thorne S, Perrin KJ, Tolani N, Das P, Delclos ME, Iyengar P, Reed VK, Horace P, Salehpour MR. Radiation for Hodgkin's Lymphoma in Young Female Patients: A New Technique to Avoid the Breasts and Decrease the Dose to the Heart. Int J Radiat Oncol Biol Phys 79(2):503-507, 2/2011. e-Pub 4/2010. PMID: 20418023.
33. Mok H, Crane CH, Palmer MB, Briere TM, Beddar S, Delclos ME, Krishnan S, Das P. Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. Radiat Oncol 6:63, 2011.
34. Silberfein EJ, Kattepogu KM, Hu CY, Skibber JM, Rodriguez-Bigas MA, Feig B, Das P, Krishnan S, Crane C, Kopetz S, Eng C, Chang GJ. Long-term Survival and Recurrence Outcomes Following Surgery for Distal Rectal Cancer. Ann Surg Oncol 17(11):2863-2869, 11/2010. e-Pub 6/15/2010. PMID: 20552409.
35. Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo LJ, Calvo FA, García-Aguilar J, Glynne-Jones R, Haustermans K, Mohiuddin M, Pucciarelli S, Small W, Suárez J, Theodoropoulos G, Biondo S, Beets-Tan RG, Beets GL. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11(9):835-844, 9/2010. e-Pub 8/6/2010. PMID: 20692872.
36. Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Bedi M, Krishnan S, Crane CH. Hyperfractionated Accelerated Radiotherapy for Rectal Cancer in Patients with Prior Pelvic Irradiation. Int J Radiat Oncol Biol Phys 77(1):60-65, 5/2010. e-Pub 8/2009. PMID: 19695792.
37. Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G. Gastric cancer. J Natl Compr Canc Netw 8(4):378-409, 4/2010. PMID: 20410333.
38. Ajani JA, Wang X, Izzo JG, Crane CH, Eng C, Skibber JM, Das P, Rashid A. Molecular Biomarkers Correlate with Disease-Free Survival in Patients with Anal Canal Carcinoma Treated with Chemoradiation. Dig Dis Sci 55(4):1098-1105, 4/2010. e-Pub 4/2009. PMID: 19399614.
39. Das P, Jiang Y, Lee JH, Bhutani MS, Ross WA, Mansfield PF, Ajani JA. Multimodality Approaches to Localized Gastric Cancer. J Natl Compr Canc Netw 8(4):417-425, 4/2010. PMID: 20410334.
40. Crane CH, Eng C, Feig BW, Das P, Skibber JM, Chang GJ, Wolff RA, Krishnan S, Hamilton S, Janjan NA, Maru DM, Ellis LM, Rodriguez-Bigas MA. Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys 76(3):824-830, 3/1/2010. e-Pub 5/21/2009. PMID: 19464823.
41. Smith KD, Tan D, Das P, Chang GJ, Kattepogu K, Feig BW, Skibber JM, Rodriguez-Bigas MA. Clinical Significance of Acellular Mucin in Rectal Adenocarcinoma Patients With a Pathologic Complete Response to Preoperative Chemoradiation. Ann Surg 251(2):261-264, 2/2010. PMID: 19864936.
42. Callender GG, Das P, Rodriguez-Bigas MA, Skibber JM, Crane CH, Krishnan S, Delclos ME, Feig BW. Local Excision After Preoperative Chemoradiation Results in an Equivalent Outcome to Total Mesorectal Excision in Selected Patients with T3 Rectal Cancer. Ann Surg Oncol 17(2):441-447, 2/2010. e-Pub 10/22/2009. PMID: 19847569.
43. Das P, Cantor SB, Parker CL, Zampieri JB, Baschnagel A, Eng C, Delclos ME, Krishnan S, Janjan NA, Crane CH. Long-Term Quality of Life after Radiation Therapy for Treatment of Anal Cancer. Cancer 116(4):822-829, 2/2010. e-Pub 2009. PMID: 20041481.
44. Ng A, Constine LS, Advani R, Das P, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ. ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma. Curr Probl Cancer 34:211-227, 2010.
45. Hodges JC, Das P, Eng C, Reish AG, Beddar AS, Delclos ME, Krishnan S, Crane CH. Intensity-Modulated Radiation Therapy for the Treatment of Squamous Cell Anal Cancer with Para-Aortic Nodal Involvement. Int J Radiat Oncol Biol Phys 75(3):791-794, 11/1/2009. e-Pub 2/21/2009. PMID: 19231109.
46. Park HC, Janjan NA, Mendoza TR, Lin EH, Vadhan-Raj S, Hundal M, Zhang Y, Delclos ME, Crane CH, Das P, Wang XS, Cleeland CS, Krishnan S. Temporal Patterns of Fatigue Predict Pathologic Response in Patients Treated with Preoperative Chemoradiation Therapy for Rectal Cancer. Int J Radiat Oncol Biol Phys 75(3):775-781, 11/1/2009. e-Pub 2/21/2009. PMID: 19231100.
47. Chang GJ, Gonzalez RJ, Skibber JM, Eng C, Das P, Rodriguez-Bigas MA. A Twenty-year Experience with Adenocarcinoma of the Anal Canal. Dis Colon Rectum 52:1375-1380, 2009. PMID: 19617747.
48. Haque W, Crane CH, Krishnan S, Delclos ME, Javle M, Garrett CR, Wolff RA, Das P. Reirradiation to the abdomen for gastrointestinal malignancies. Radiat Oncol 4:55, 2009. PMCID: PMC2787526.
49. Herman MP, Kopetz S, Bhosale PR, Eng C, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Delclos ME, Krishnan S, Crane CH, Das P. Sacral Insufficiency Fractures After Preoperative Chemoradiation for Rectal Cancer: Incidence, Risk Factors, and Clinical Course. Int J Radiat Oncol Biol Phys 74:818-823, 2009. PMID: 19147305.
50. Das P, Ng A, Constine LS, Hodgson DC, Mendenhall NP, Morris DE, Yunes MJ, Chauvenet AR, Hudson MM, Winter JN. ACR Appropriateness Criteria on Hodgkin's lymphoma - Favorable prognosis stage I and II. J Am Coll Radiol 5:1054-1066, 2008.
51. Kim MM, Mansfield PF, Das P, Janjan NA, Badgwell BD, Phan AT, Delclos ME, Maru D, Ajani JA, Crane CH, Krishnan S. Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery. Int J Radiat Oncol Biol Phys 71(1):167-172, 2008. PMID: 18406886.
52. Kim MM, Rana V, Janjan NA, Das P, Phan AT, Delclos ME, Mansfield PF, Ajani JA, Crane CH, Krishnan S. Clinical benefit of palliative radiation therapy in advanced gastric cancer. Acta Oncol 47(3):421-427, 2008. e-Pub 2007. PMID: 17899453.
53. Myerson RJ, Garofalo MC, Naga IE, Abrams RA, Apte A, Bosch WR, Das P, Gunderson LL, Hong TS, Kim JJ, Willett CG, Kachnic LA. Elective clinical target volumes for conformal therapy in anorectal cancer: An Radiation Therapy Oncology Group Consensus Panel Contouring Atlas. Int J Radiat Oncol Biol Phys 74:824-830, 2008.
54. Borghero Y, Crane CH, Szklaruk J, Oyarzo M, Curley S, Pisters PW, Evans D, Abdalla EK, Thomas MB, Das P, Wistuba II, Krishnan S, Vauthery JN. Extrahepatic bile duct adenocarcinoma: Patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol 15(11):3147-3156, 2008. e-Pub 8/2008. PMID: 18754070.
55. Reed VK, Krishnan S, Mansfield PF, Bhosale PR, Kim M, Das P, Janjan NA, Delclos ME, Lowy AM, Feig BW, Pisters PW, Ajani JA, Crane CH. Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 71(3):741-747, 2008. e-Pub 2007. PMID: 18164837.
56. Yu T-K, Bhosale PR, Crane CH, Iyer RB, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Das P. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 71(4):1175-1180, 2008. e-Pub 1/2008. PMID: 18207667.
57. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee J, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26(21):3487-3495, 2008. PMID: 18640929.
58. Das P, Crane CH, Eng C, Ajani JA. Prognostic factors for squamous cell cancer of the anal canal. Gastrointest Cancer Res 2(1):1-14, 2008. PMID: 19259318.
59. Krishnan S, Rana V, Evans DB, Varadhachary G, Das P, Bhatia S, Delclos ME, Janjan NA, Wolff RA, Crane CH, Pisters PW. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of Vater. Int J Radiat Oncol Biol Phys 70(3):735-743, 2008. e-Pub 2008. PMID: 17980502.
60. Bedi M, Das P, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Eng C, Wolff RA, Janjan NA, Krishnan S, Crane CH. Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer. Gastrointest Cancer Res 1:44-48, 2007.
61. Krishnan S, Rana V, Janjan NA, Varadhachary GR, Abbruzzese JL, Das P, Delclos ME, Gould MS, Evans DB, Wolff RA, Crane CH. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. Cancer 110:47-55, 2007.
62. Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Delclos ME, Krishnan S, Janjan NA, Crane CH. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Biol Phys 68:794-800, 2007.
63. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Wolff RA, Eng C, Krishnan S, Janjan NA, Crane CH. Predictors of tumor response and downstaging in patients treated with preoperative chemoradiation for rectal cancer. Cancer 109:1750-1755, 2007.
64. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Levy LB, Ellis LM, Crane CH. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 29:219-224, 2006. PMID: 16755173.
65. Das P, Fukami N, Ajani JA. Combined modality therapy of localized gastric and esophageal cancers. J Natl Compr Canc Netw 4:375-382, 2006. PMID: 16569390.
66. Das P, Ng AK, Earle CC, Mauch PM, Kuntz KM. Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis. Ann Oncol 17:785-793, 2006. PMID: 16500905.
67. Das P, Wolff RA, Abbruzzese JL, Varadhachary GR, Evans DB, Vauthey JN, Baschnagel A, Delclos ME, Krishnan S, Janjan NA, Crane CH. Concurrent capecitabine and upper abdominal radiation therapy is well tolerated. Radiat Oncol 1:41, 2006. PMID: 17062148.
68. Krishnan S, Lin EH, Gunn GB, Chandra A, Beddar AS, Briere TM, Das P, Delclos ME, Janjan NA, Crane CH. Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases. Am J Clin Oncol 29:562-567, 2006. PMID: 17148992.
69. Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, Delclos ME, Chang GJ, Hoff PM, Eng C, Brown TD, Crane CH, Feig BW, Morris J, Vadhan-Raj S, Hamilton SR, Lin EH. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 66:762-771, 2006. PMID: 17011451.
70. Das P, Lin EH, Bhatia S, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Delclos ME, Krishnan S, Janjan NA, Crane CH. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys 66:1378-1383, 2006. PMID: 17056196.
71. Krishnan S, Rana V, Janjan NA, Abbruzzese JL, Gould MS, Das P, Delclos ME, Palla S, Guha S, Varadhachary G, Evans DB, Wolff RA, Crane CH. Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. Cancer 107:2589-2596, 2006. PMID: 17083124.
72. Beddar AS, Krishnan S, Briere TM, Wang X, Delclos ME, Ballo MT, Das P, Gould S, Horton JL, Crane CH. The optimization of dose delivery for intraoperative high-dose-rate radiation therapy using curved HAM applicators. Radiother Oncol 78:207-212, 2006. PMID: 16376445.
73. Das P, Ng AK, Stevenson MA, Mauch PM. Clinical course of thoracic cancers in Hodgkin's disease survivors. Ann Oncol 16:793-797, 2005. PMID: 15802277.
74. Das P, Ajani JA. Gastric and gastro-oesophageal cancer therapy. Expert Opin Pharmacother 6:2805-2812, 2005. PMID: 16318431.
75. Das P, Kaplan I. The role of PC-SPES, selenium, and vitamin E in prostate cancer. Oncology (Williston Park) 16:285-291; discussion 291, 295-296, 299-300, 2002. PMID: 15046388.
76. Das P, Chen MH, Valentine K, Lopes L, Cormack RA, Renshaw AA, Tempany CM, Kumar S, D'Amico AV. Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce. Int J Radiat Oncol Biol Phys 54:698-702, 2002. PMID: 12377320.

Invited Articles

1. Cox JA, Crane CH, Das P. Do We Need Intensity Modulated Radiation Therapy (IMRT) Routinely in the Preoperative Setting for Rectal Cancer? Curr Colorectal Cancer Rep 8(2):99-104, 2012.
2. Tsai CJ, Das P. Impact of PET/CT-Based Radiation Therapy Planning in Gastrointestinal Malignancies. PET Clinics 6:185-193, 2011.
3. Das P, Crane CH. Predictors of Outcome for Anal Cancer. Radiat Med Rounds 1:391-398, 2010.
4. Das P, Crane CH. Staging, Prognostic Factors and Therapy of Localized Rectal Cancer. Curr Oncol Rep 11(3):167-174, 5/2009. PMID: 19336008.
5. Das P. Preoperative Chemoradiotherapy for Stage III Rectal Cancer. Gastrointest Cancer Res 2(6):302-304, 11/2008. PMID: 19259282.
6. Das P, Crane CH, Ajani JA. Current treatment for localized anal carcinoma. Curr Opin Oncol 19:396-400, 2007.
7. Crane CH, Das P. Potential benefits of integration of targeted therapies with chemoradiation in rectal cancer. Gastrointest Cancer Res 1:S77-S84, 2007.
8. Das P, Crane CH. Preoperative and adjuvant treatment of localized rectal cancer. Curr Oncol Rep 8:167-173, 2006. PMID: 16618380.

Editorials

1. Das P. Rectal cancer: Do protons have prospects? J Gastrointest Oncol, 2013.
2. Das P, Strong VE, Ajani JA. Adjuvant and neoadjuvant therapy for gastric cancer: taking stock of the options. Gastrointest Cancer Res 5(6):203-204, 2012.
3. Das P. Esophageal cancer: Is preoperative chemoradiation the new standard? J Gastrointest Oncol 1. e-Pub 2010.

Book Chapters

1. Tan CH, Das P, Silberfein EJ, Rodriguez-Bigas M, Iyer RB. Colorectal Cancer. In: Oncologic Imaging: A Multidisciplinary Approach. Ed(s) Silverman PM. Elsevier: Philadelphia, 267-286, 2012.
2. Bhosale P, Fleming J, Das P, Javle M, Lee JH. Cystic Pancreatic Lesions. In: Oncologic Imaging: A Multidisciplinary Approach. Ed(s) Silverman PM. Elsevier: Philadelphia, 173-191, 2012.
3. Alberts SR, Citrin D, Rodriguez-Bigas M, Das P. Colon, rectal and anal cancers. In: Cancer Management: A Multidisciplinary Approach, 12. Ed(s) Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ. CMPMedica: Norwalk, CT, 329-363, 2010.
4. Das P, Ludwig M, Janjan NA, Crane CH. The Anal Region. In: Radiation Oncology, 9th. Ed(s) JD Cox, KK Ang. Elsevier: Philadelphia, 606-623, 2009.
5. Janjan NA, Delclos ME, Crane CH, Krishnan S, Das P. The Colon and Rectum. In: Radiation Oncology, 9th. Ed(s) JD Cox, KK Ang. Elsevier: Philadelphia, 560-605, 2009.
6. Krishnan S, Das P, Crane CH. The Liver and Biliary System. In: Radiation Oncology, 9th. Ed(s) JD Cox, KK Ang. Elsevier: Philadelphia, 534-559, 2009.
7. Das P, Rodriguez-Bigas MA, Hoff PM, Crane CH. Neoadjuvant and adjuvant therapy for rectal adenocarcinoma. In: Advanced Therapy in Surgical Oncology. Ed(s) Pollock RE, Curley SA, Ross MI, Perrier NE. BC Decker: Hamilton, Ontario, 308-315, 2008.
8. Janjan N, Mahajan A, Chang EL, McCutcheon I, Lin E, Das P, Krishnan S, Chow E. Prognosis in Spinal Cord Compression. In: Prognosis in Advanced Cancer. Ed(s) Glare P, Christakis NA. Oxford University Press, 329-344, 2008.
9. Janjan N, Krishnan S, Das P, Gould MS, Zampieri J, Crane C, Delclos M, Cleeland C, Lutz ST, Chow E. Palliative Radiation Therapy Techniques. In: Cancer Pain Management. Ed(s) MJ Fisch, AW Burton. McGraw Hill, 271-293, 2007.

Last updated: 1/7/2014